Literature DB >> 14699119

Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1.

Veerle Vulsteke1, Monique Beullens, An Boudrez, Stefaan Keppens, Aleyde Van Eynde, Mark H Rider, Willy Stalmans, Mathieu Bollen.   

Abstract

NIPP1 is a ubiquitous nuclear protein that is required for spliceosome assembly. We report here that the phosphothreonine-binding Forkhead-associated domain of NIPP1 interacts with the cell cycle-regulated protein Ser/Thr kinase MELK (maternal embryonic leucine zipper kinase). The NIPP1-MELK interaction was critically dependent on the phosphorylaton of Thr-478 of MELK and was increased in lysates from mitotically arrested cells. Recombinant MELK was a potent inhibitor of an early step of spliceosome assembly in nuclear extracts. This splicing defect was also seen with a kinase-dead mutant but was absent after mutation (T478A) of the NIPP1 binding site of MELK, indicating a mediatory role for NIPP1. Our data suggest that MELK has a role in the cell cycle-regulated control of pre-mRNA splicing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14699119     DOI: 10.1074/jbc.M311466200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Murine protein serine-threonine kinase 38 activates p53 function through Ser15 phosphorylation.

Authors:  Hyun-A Seong; Hyunjung Ha
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

2.  The NMR structure of the NIPP1 FHA domain.

Authors:  Hiroyuki Kumeta; Kenji Ogura; Souichirou Adachi; Yuko Fujioka; Nobuhiro Tanuma; Kiminobu Tanuma; Kunimi Kikuchi; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2008-02-06       Impact factor: 2.835

3.  Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression.

Authors:  Kalyan Dulla; Henrik Daub; Renate Hornberger; Erich A Nigg; Roman Körner
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

4.  Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1.

Authors:  Lakshmi Reddy Bollu; Jonathan Shepherd; Dekuang Zhao; Yanxia Ma; William Tahaney; Corey Speers; Abhijit Mazumdar; Gordon B Mills; Powel H Brown
Journal:  NPJ Breast Cancer       Date:  2020-01-03

5.  Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells.

Authors:  Cenk Kig; Monique Beullens; Lijs Beke; Aleyde Van Eynde; Johannes T Linders; Dirk Brehmer; Mathieu Bollen
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

6.  Cortical localization of maternal embryonic leucine zipper kinase (MELK) implicated in cytokinesis in early xenopus embryos.

Authors:  Jean-Pierre Tassan
Journal:  Commun Integr Biol       Date:  2011-07-01

7.  Murine protein serine/threonine kinase 38 stimulates TGF-beta signaling in a kinase-dependent manner via direct phosphorylation of Smad proteins.

Authors:  Hyun-A Seong; Haiyoung Jung; Hyunjung Ha
Journal:  J Biol Chem       Date:  2010-07-21       Impact factor: 5.157

8.  PDK1 protein phosphorylation at Thr354 by murine protein serine-threonine kinase 38 contributes to negative regulation of PDK1 protein activity.

Authors:  Hyun-A Seong; Haiyoung Jung; Ravi Manoharan; Hyunjung Ha
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

9.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

10.  The nuclear scaffold protein NIPP1 is essential for early embryonic development and cell proliferation.

Authors:  Aleyde Van Eynde; Mieke Nuytten; Mieke Dewerchin; Luc Schoonjans; Stefaan Keppens; Monique Beullens; Lieve Moons; Peter Carmeliet; Willy Stalmans; Mathieu Bollen
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.